# Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients

> **NCT07067853** · NA · COMPLETED · sponsor: **Indonesia University** · enrollment: 30 (actual)

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Lidocaine 2 % Pharmacopuncture
- **DRUG:** propranolol 20mg

## Key facts

- **NCT ID:** NCT07067853
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07067853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07067853, "Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07067853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*